LH insider buying and SEC filings, explained
Labcorp Holdings Inc. · CIK 920148
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- NYSE
- Industry (SIC)
- Services-Medical Laboratories
- Fiscal year end
- Dec 31
- Former names
- LABORATORY CORP OF AMERICA HOLDINGS; NATIONAL HEALTH LABORATORIES HOLDINGS INC
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$5.5M
Planned sales (10b5-1)
$8.2M
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Oct 30, 2026 | Sale | Richelle P Parham (Director) sold 1,078 shares at $361.22 ($389K). Holdings down 32% to 2,288 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 3, 2026, 10:17 AM ET |
| Aug 17, 2026 | Planned (10b5-1) | Kerrii B. Anderson (Director) sold 3,000 shares at $318.02 ($954K), marked as a 10b5-1 plan trade. Holdings down 31% to 6,563 shares. | SEC filing Filed Aug 18, 2026 |
| Aug 11, 2026 | Planned (10b5-1) | Adam H Schechter (CEO and Director) sold 4,669 shares at $320.37 ($1.5M), marked as a 10b5-1 plan trade. Holdings down 4% to 102,565 shares. | SEC filing Filed Aug 12, 2026 |
| Aug 4, 2026 | Sale | Amy B. Summy (EVP, Chief Marketing Officer) sold 924 shares at $306.74 ($283K). Holdings down 12% to 6,956 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 6, 2026 |
| Jul 2, 2026 | Planned (10b5-1) | Kathryn W Kyle (EVP, Chief Legal Officer) sold 92 shares at $286.19 ($26K), marked as a 10b5-1 plan trade. Holdings down 2% to 3,904 shares. | SEC filing Filed Jul 6, 2026 |
| Jul 2, 2026 | Planned (10b5-1) | Bryan T Vaughn (President / COO) sold 234 shares at $286.19 ($67K), marked as a 10b5-1 plan trade. Holdings down 3% to 6,746 shares. | SEC filing Filed Jul 6, 2026 |
| Jun 8, 2026 | Planned (10b5-1) | Kathryn W Kyle (EVP, Chief Legal Officer) sold 762 shares at $263.89 ($201K), marked as a 10b5-1 plan trade. Holdings down 17% to 3,813 shares. | SEC filing Filed Jun 10, 2026 |
| May 11, 2026 | Planned (10b5-1) | Adam H Schechter (CEO and Director) sold 5,903 shares at $254.50 ($1.5M), marked as a 10b5-1 plan trade. Holdings down 5% to 107,234 shares. | SEC filing Filed May 13, 2026 |
| Mar 27, 2026 | Planned (10b5-1) | Peter J Wilkinson (SVP, Chief Accounting Officer) sold 1,633 shares at $267.05 ($436K), marked as a 10b5-1 plan trade. Holdings down 47% to 1,852 shares. | SEC filing Filed Mar 30, 2026 |
| Mar 27, 2026 | Planned (10b5-1) | Jonathan C Meltzer (EVP, Operations) sold 839 shares at $267.05 ($224K), marked as a 10b5-1 plan trade. Holdings down 19% to 3,620 shares. | SEC filing Filed Mar 30, 2026 |
| Mar 3, 2026 | Sale | Adam H Schechter (CEO and Director) sold 8,705 shares at $279.96 ($2.4M). Holdings down 10% to 80,773 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 5, 2026 |
| Feb 27, 2026 | Sale | der Vaart Sandra D van (EVP, Corporate Affairs) sold 548 shares at $284.91 ($156K). Holdings down 18% to 2,579 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 3, 2026 |
| Feb 24, 2026 | Sale | Brian J Caveney (EVP, Pres of ED, CMO & CSO) sold 1,500 shares at $286.31 ($429K). Holdings down 5% to 30,107 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 26, 2026 |
| Feb 19, 2026 | Planned (10b5-1) | Peter J Wilkinson (SVP, Chief Accounting Officer) sold 666 shares at $277.94 ($185K), marked as a 10b5-1 plan trade. Holdings down 26% to 1,852 shares. | SEC filing Filed Feb 23, 2026 |
| Feb 11, 2026 | Planned (10b5-1) | Adam H Schechter (CEO and Director) sold 5,273 shares at $284.38 ($1.5M), marked as a 10b5-1 plan trade. Holdings down 6% to 87,343 shares. | SEC filing Filed Feb 13, 2026 |
| Feb 12, 2026 | Planned (10b5-1) | Jonathan C Meltzer (EVP, Operations) sold 87 shares at $290.42 ($25K), marked as a 10b5-1 plan trade. Holdings down 3% to 2,782 shares. | SEC filing Filed Feb 13, 2026 |
| Feb 10, 2026 | Planned (10b5-1) | Jonathan C Meltzer (EVP, Operations) sold 91 shares at $276.79 ($25K), marked as a 10b5-1 plan trade. Holdings down 3% to 2,696 shares. | SEC filing Filed Feb 12, 2026 |
| Feb 9, 2026 | Planned (10b5-1) | Jonathan C Meltzer (EVP, Operations) sold 88 shares at $275.53 ($24K), marked as a 10b5-1 plan trade. Holdings down 3% to 2,869 shares. | SEC filing Filed Feb 10, 2026 |
| Nov 11, 2025 | Planned (10b5-1) | Adam H Schechter (CEO and Director) sold 5,745 shares at $262.75 ($1.5M), marked as a 10b5-1 plan trade. Holdings down 6% to 87,574 shares. | SEC filing Filed Nov 13, 2025 |
| Oct 31, 2025 | Sale | Richelle P Parham (Director) sold 7,009 shares at $254.28 ($1.8M). Holdings down 74% to 2,469 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 4, 2025 |
80 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
| Filed | Items | Tag | Source |
|---|---|---|---|
| Oct 28, 2026, 6:57 AM ET 8-K | Earnings released (Item 2.02) | SEC filing |
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow LH in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.